PacBio Completes Sale of Short-Read Sequencing Assets
PacBio Completes Sale of Short-Read Sequencing Assets GlobeNewswire February 02, 2026 MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio's short-read DNA sequencing technology and related […]